Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Chemoradiation With Oxaliplatin and 5FU for Locally Advanced Pancreatic Cancer
NCT00463840Phase 2Terminated
- Sponsor
- NYU Langone Health
- Start
- Jun 2004
- Primary completion
- Jul 2010
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
A Phase 2 trial of oxaliplatin in pancreatic cancer (PC), sponsored by NYU Langone Health. Started Jun 2004; status: terminated.
02
Drugs
oxaliplatin
03
Conditions
pancreatic cancer (PC)
Beyond the preview
Go deeper on NCT00463840.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00463840.